SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001764013-21-000054
Filing Date
2021-06-10
Accepted
2021-06-10 09:50:00
Documents
2
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_162333298508532.html 3  
1 FORM 3 wf-form3_162333298508532.xml 3 1723
2 POWER OF ATTORNEY FOR: /S/ PAMELA YANCHIK CONNEALY, ATTORNEY-IN-FACT FOR WILLIAM poa.htm EX-24 4136
  Complete submission text file 0001764013-21-000054.txt   7341
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IMMUNOVANT, INC. 320 WEST 37TH STREET, 6TH FLOOR NEW YORK NY 10018
Business Address
Macias William L. (Reporting) CIK: 0001864280 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38906 | Film No.: 211007125